Qiagen (QGEN) Expected to Announce Quarterly Earnings on Wednesday

Qiagen (NYSE:QGENGet Free Report) is projected to issue its quarterly earnings data after the market closes on Wednesday, February 5th. Analysts expect the company to announce earnings of $0.60 per share and revenue of $518.54 million for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

Qiagen Stock Performance

NYSE:QGEN opened at $43.85 on Tuesday. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.17 and a quick ratio of 1.89. The firm has a market capitalization of $9.73 billion, a price-to-earnings ratio of 109.31, a PEG ratio of 3.10 and a beta of 0.37. The company’s 50-day moving average is $43.75 and its two-hundred day moving average is $43.23. Qiagen has a 1-year low of $40.15 and a 1-year high of $49.30.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. HSBC lowered shares of Qiagen from a “buy” rating to a “hold” rating and set a $47.64 price objective on the stock. in a report on Thursday, October 17th. Morgan Stanley reiterated an “equal weight” rating and set a $46.67 target price (down from $48.61) on shares of Qiagen in a report on Monday, January 6th. Jefferies Financial Group reiterated a “buy” rating and set a $52.50 target price (up from $40.83) on shares of Qiagen in a report on Tuesday, December 10th. Finally, Hsbc Global Res upgraded shares of Qiagen to a “hold” rating in a report on Thursday, October 17th. Four analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, Qiagen currently has a consensus rating of “Moderate Buy” and an average target price of $50.07.

Read Our Latest Research Report on QGEN

About Qiagen

(Get Free Report)

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

Recommended Stories

Earnings History for Qiagen (NYSE:QGEN)

Receive News & Ratings for Qiagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qiagen and related companies with MarketBeat.com's FREE daily email newsletter.